Article Details
Retrieved on: 2021-01-08 20:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Two of the experimental treatments currently used on critically ill Covid-19 patients, convalescent plasma and monoclonal antibody drugs, rely heavily ...
Article found on: www.forbes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here